Protein array technology to detect HER2 (erbB-2)-induced ‘cytokine signature’ in breast cancer
- 1 May 2007
- journal article
- research article
- Published by Elsevier in European Journal Of Cancer
- Vol. 43 (7) , 1117-1124
- https://doi.org/10.1016/j.ejca.2007.01.037
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Amplification of Her-2/neu Gene in Her-2/neu-Overexpressing and -Nonexpressing Breast Carcinomas and Their Synchronous Benign, Premalignant, and Metastatic Lesions Detected by FISH in Archival MaterialLaboratory Investigation, 2002
- Biology of HER2 and Its Importance in Breast CancerOncology, 2001
- Untangling the ErbB signalling networkNature Reviews Molecular Cell Biology, 2001
- Molecular mechanisms underlying ErbB2/HER2 action in breast cancerOncogene, 2000
- Role of erbB2 in breast cancer chemosensitivityBioEssays, 2000
- Biochemistry of HER2 Oncogenesis in Breast CancerBreast Disease, 2000
- The role of ErbB-2 tyrosine kinase receptor in cellular intrinsic chemoresistance: mechanisms and implicationsBiochemistry and Cell Biology, 1997
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989
- erb B-2 Is a Potent Oncogene When Overexpressed in NIH/3T3 CellsScience, 1987
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987